| Togashi et al35 | Genomic rearrangement in MYB/MYBL1 locus | Likely diagnostic marker of adenoid cystic carcinoma |
| Nakamura et al34 | MYBL1-NFIB gene fusion involving t(8;9) | Novel oncogenic mechanisms likely occur in a sub-set of vulvar adenoid cystic carcinomas |
| KRAS mutations | Novel pathway related to adenoid cystic carcinoma of the Bartholin’s gland carcinogenesis→future gene-targeted therapy |
| KDM6A mutations | Similar to adenoid cystic carcinomas of the salivary gland→gene-targeted therapy (bromodomain and extra-terminal motif (BET) protein inhibitors and romidepsin) |